Starting July 1, 2026, the two organizations began consolidating their business objectives to leverage complementary strengths. BIOLASE remains the primary hub for research, development, and manufacturing, specifically utilizing its expanded infrastructure in Corona, California. Meanwhile, MegaGen America assumes leadership of the commercial front, overseeing sales, marketing, and customer service operations.
In section Releases
BIOLASE and MegaGen America Merge U.S. Commercial Operations
Dental laser innovator BIOLASE and implant specialist MegaGen America have launched a unified commercial strategy in the United States. Following BIOLASE’s integration into the MegaGen family, the collaboration aligns manufacturing excellence with expanded sales and clinical support networks to streamline services for dental professionals nationwide.
Jeff Selph, Director of Sales for North America, stated that the partnership aims to move beyond simple organizational alignment, focusing instead on shared clinical education and improved patient care outcomes. Despite the integration, both companies will maintain their distinct brand identities to preserve established customer trust. Kristina Diluzio, Managing Director at MegaGen America, noted that this division of labor allows each firm to focus on core competencies, creating a more agile structure for the evolving dental market.
Comments (0)
No comments yet. Be the first!